IL79254A0 - Compositions for preventing graft rejection - Google Patents

Compositions for preventing graft rejection

Info

Publication number
IL79254A0
IL79254A0 IL79254A IL7925486A IL79254A0 IL 79254 A0 IL79254 A0 IL 79254A0 IL 79254 A IL79254 A IL 79254A IL 7925486 A IL7925486 A IL 7925486A IL 79254 A0 IL79254 A0 IL 79254A0
Authority
IL
Israel
Prior art keywords
heparin
compositions
graft rejection
humans
preventing graft
Prior art date
Application number
IL79254A
Other languages
English (en)
Original Assignee
Hadassah Med Org
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL79254A priority Critical patent/IL79254A0/xx
Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org
Publication of IL79254A0 publication Critical patent/IL79254A0/xx
Priority to EP87108976A priority patent/EP0251134B1/de
Priority to DE8787108976T priority patent/DE3782686T2/de
Priority to ES87108976T priority patent/ES2052514T3/es
Priority to AT87108976T priority patent/ATE82502T1/de
Priority to AU74706/87A priority patent/AU608228B2/en
Priority to NO872675A priority patent/NO872675L/no
Priority to DK331287A priority patent/DK169422B1/da
Priority to JP62159514A priority patent/JP2527749B2/ja
Priority to CA000540717A priority patent/CA1318591C/en
Priority to US07/583,851 priority patent/US5206223A/en
Priority to GR930400069T priority patent/GR3006814T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Soil Working Implements (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL79254A 1986-06-26 1986-06-26 Compositions for preventing graft rejection IL79254A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection
EP87108976A EP0251134B1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur Vorbeugung von Plastik-Abstossung
DE8787108976T DE3782686T2 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastik-abstossung.
ES87108976T ES2052514T3 (es) 1986-06-26 1987-06-23 Un procedimiento para la preparacion de composiciones farmaceuticas eficaces contra enfermedades autoinmunes.
AT87108976T ATE82502T1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung.
AU74706/87A AU608228B2 (en) 1986-06-26 1987-06-25 Compositions for preventing graft rejection
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer
DK331287A DK169422B1 (da) 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse
JP62159514A JP2527749B2 (ja) 1986-06-26 1987-06-26 移植拒否反応抑制または自己免疫疾患治療用薬学的組成物
CA000540717A CA1318591C (en) 1986-06-26 1987-06-26 Composition containing heparin or derivative thereof
US07/583,851 US5206223A (en) 1986-06-26 1990-09-17 Method for inhibiting heparanase activity
GR930400069T GR3006814T3 (de) 1986-06-26 1993-01-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (1)

Publication Number Publication Date
IL79254A0 true IL79254A0 (en) 1986-09-30

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Country Status (10)

Country Link
EP (1) EP0251134B1 (de)
JP (1) JP2527749B2 (de)
AT (1) ATE82502T1 (de)
AU (1) AU608228B2 (de)
DE (1) DE3782686T2 (de)
DK (1) DK169422B1 (de)
ES (1) ES2052514T3 (de)
GR (1) GR3006814T3 (de)
IL (1) IL79254A0 (de)
NO (1) NO872675L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
EP0998941B9 (de) 1997-07-14 2007-03-14 Takashi Muramatsu Verwendung von midkin oder von anti-midkin antikörper
US20050137167A1 (en) 2001-09-12 2005-06-23 Benito Casu Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
EP2165711B1 (de) 2004-05-27 2014-05-21 Baxter International Inc. Verfahren zur Behandlung von Blutungsstörungen mittels sulfatierter Polysaccharide
JP5896742B2 (ja) 2008-08-22 2016-03-30 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ 出血性障害を処置するための方法
WO2011088267A1 (en) 2010-01-14 2011-07-21 Baxter International Inc. Methods and compositions for treating bleeding disorders
EP2734213B1 (de) 2011-07-19 2018-06-06 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung nicht-antikoagulierender sulfatierter polysaccharide
CA2881785A1 (en) 2012-08-14 2014-02-20 Baxter International Inc. Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
EP2968400B1 (de) 2013-03-12 2019-05-08 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung von niedermolekularen heparinen
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
WO2016198578A1 (en) * 2015-06-11 2016-12-15 Universiteit Maastricht Method for preventing transplant failure in a host.
AU2023203192B2 (en) * 2022-05-06 2024-03-14 Bargent Therapeutics Pty Limited Methods of treating allograft rejection

Also Published As

Publication number Publication date
DE3782686T2 (de) 1993-06-09
EP0251134A3 (en) 1989-05-03
AU608228B2 (en) 1991-03-28
DK331287D0 (da) 1987-06-26
EP0251134B1 (de) 1992-11-19
NO872675D0 (no) 1987-06-25
ES2052514T3 (es) 1994-07-16
NO872675L (no) 1987-12-28
DK169422B1 (da) 1994-10-31
EP0251134A2 (de) 1988-01-07
JPS6388127A (ja) 1988-04-19
AU7470687A (en) 1988-01-07
DE3782686D1 (de) 1992-12-24
ATE82502T1 (de) 1992-12-15
GR3006814T3 (de) 1993-06-30
JP2527749B2 (ja) 1996-08-28
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
EP0251134A3 (en) Compositions for preventing graft rejection
EP0184040A3 (en) Method and system for removing immunosuppressive components from the blood of mammals
AU560251B2 (en) Pharmaceutical compositions of mopidamol
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
ZA884936B (en) Edible plastic disperson
NZ210275A (en) Modified hirudin and its antithrombin properties
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
PL308770A1 (en) Oak bark extract compositions, similar synthetic composition and method of obtaining them
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
MY105522A (en) Composition for treating seeds.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
EP0376251A3 (en) An anticoagulant substance obtained from urine
SE9002550D0 (sv) Heparinfragment
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0058397A3 (de) Antikoagulans und seine Verwendung
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0346810A3 (de) Heparin zur Behandlung von Lupus
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
EP0347907A3 (de) Antithrombosemittel auf Basis von derivatisiertem Heparin
DE3270466D1 (en) Pharmaceutical composition